1. Home
  2. CTSO vs IPWR Comparison

CTSO vs IPWR Comparison

Compare CTSO & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.73

Market Cap

49.7M

Sector

Health Care

ML Signal

HOLD

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

HOLD

Current Price

$3.90

Market Cap

42.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
IPWR
Founded
1997
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
49.7M
42.8M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CTSO
IPWR
Price
$0.73
$3.90
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.38
$10.75
AVG Volume (30 Days)
126.1K
84.2K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,979,520.00
$43,136.00
Revenue This Year
$9.51
N/A
Revenue Next Year
$24.40
$3,233.33
P/E Ratio
N/A
N/A
Revenue Growth
23.89
N/A
52 Week Low
$0.60
$3.06
52 Week High
$1.61
$8.62

Technical Indicators

Market Signals
Indicator
CTSO
IPWR
Relative Strength Index (RSI) 46.64 45.17
Support Level $0.70 $3.06
Resistance Level $0.85 $4.06
Average True Range (ATR) 0.07 0.33
MACD 0.01 0.03
Stochastic Oscillator 52.04 80.08

Price Performance

Historical Comparison
CTSO
IPWR

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

Share on Social Networks: